These data indicate that, in malignant glioma cells, the specific inhibition of GSK3β and the maintenance of GSK3α activity would be beneficial in repressing cell proliferation, confirming that GSK3 paralogs antagonistically regulate glioma cell survival and proliferation. The gene discussed is GSK3A; the disease is central nervous system cancer.